Securities Fraud Investigation Into Easterly ROCMuni High Income Municipal Bond Fund (RMHIC, RMHVX, RMJAX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Easterly ROCMuni High Income Municipal Bond Fund f/k/a Principal Street High Income Municipal Fund ('Easterly' or the 'Fund') (NASDAQ: RMHIX, RMHVX, RMJAX ) on behalf of investors concerning the Fund's possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON EASTERLY ROCMUNI HIGH INCOME MUNICIPAL BOND FUND (RMHIC, RMHVX, RMJAX), CLICKHERETO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.
What Is The Investigation About?
On June 13, 2025, the Fund abruptly slashed the value of its shares by 30%, with the value of shares continuing to fall in subsequent days. Industry news source The Bond Buyer reported the collapse was indicative of Fund-specific issues like 'flawed pricing,' 'illiquidity,' and the fact that the Fund was insufficiently 'diversified.' The article further noted that the Fund was heavily invested in junk investments with a 'lack of credit transparency.' According to the article, many bonds traded at a massive discount to their previously evaluated prices, including one instance where an investor paid just four cents for what had previous been represented as $3.2 million in bonds for a metal recycling company.
The total net assets of the Fund have collapsed from over $230 million as of March 31, 2025 to less than $17 million as of July 8, 2025.
Contact Us To Participate or Learn More:
If you purchased Easterly shares, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Call us at: 310-914-5007
Email us at: [email protected]
Visit our website at: www.frankcruzlaw.com.
Follow us for updates on Twitter at twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250724181316/en/
CONTACT: The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz
310-914-5007
[email protected]
www.frankcruzlaw.com
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA
INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL
SOURCE: The Law Offices of Frank R. Cruz
Copyright Business Wire 2025.
PUB: 07/24/2025 02:51 PM/DISC: 07/24/2025 02:51 PM
http://www.businesswire.com/news/home/20250724181316/en
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Metagenomi (MGX) Presents Latest in Gene Editing Technologies
Metagenomi, Inc. (NASDAQ:MGX) is one of the 11 Best New Penny Stocks to Buy Right Now. On May 14, Metagenomi, Inc. (NASDAQ:MGX) announced that it is presenting three abstracts at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting, held from May 13 to 17, 2025, in New Orleans, Louisiana. These presentations highlighted Metagenomi, Inc.'s (NASDAQ:MGX) advancements in compact nucleases for extrahepatic gene editing and CAST (CRISPR-associated transposases) for site-specific integration of large therapeutic genes. A lab scientist peering into a microscope focused on gene editing technology. The company's special metagenomics discovery platform can systematically identify and optimize novel gene editing systems through natural microbial evolution and AI-guided protein optimization. At the meeting, Metagenomi, Inc. (NASDAQ:MGX) shared early proof-of-concept data across different types of gene-editing technologies. This included compact Type II and Type V nucleases for efficient in vivo editing and a programmable Type V-K CAST system capable of targeted integration of large DNA cargoes. The small nucleases can potentially improve delivery to hard-to-reach tissues, while CAST offers promising new tools for targeted and precise large gene integration, addressing one of the greatest challenges in gene editing. Metagenomi, Inc.'s (NASDAQ:MGX) work shows promise in specifically integrating correct copies of complete genes, which could enable treatment for diseases caused by a loss-of-function mutation. Metagenomi, Inc. (NASDAQ:MGX) is a precision gene editing company focused on developing curative therapeutics using its proprietary, metagenomics-derived genome editing toolbox. While we acknowledge the potential of MGX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Apple (AAPL) Faces Margin Pressures Ahead of Earnings — BofA Still Says Buy
Apple Inc. (NASDAQ:AAPL) is one of the . On July 28, Bank of America maintained a 'Buy' rating on the stock with a price target of $235. The firm believes that Apple faces a tough setup as it heads into its third fiscal quarter results due on July 31st. Investors continue to watch closely for margin pressures from tariffs and ongoing regulatory concerns. 'We see client sentiment as fairly negative given uncertain impact from tariffs, U.S. DOJ investigation (Google (NASDAQ:GOOGL) TAC payments), App Store headwinds, and slow progress in AI.' -BofA analysts wrote in a note. The firm believes that gross margins (GM) are going to be the highlight of the earnings report, with the June quarter guide of 46% at the mid-point, which includes the 'impact of $900mn of tariff-related costs.' Copyright: dennizn / 123RF Stock Photo It models the September quarter period as the 'trough,' anticipating gross margins to improve on the back of a 'better mix of higher ASP products, including the slim iPhone ('Air'), which we expect Apple to launch this fall.' While margin concerns exist, the firm anticipates in-line results for the current quarter and also potentially a slight revenue beat. Upcoming product cycles may also prove to be good for the company, as 'iPhone form factor changes have helped drive higher replacement rates in the past.' Apple is a technology company known for its consumer electronics, software, and services. While we acknowledge the potential of AAPL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
ACI Worldwide (ACIW) Slid on Investors' Concerns Over Unchanged Guidance
The London Company, an investment management company, released 'The London Company Small Cap Strategy' second quarter 2025 investor letter. A copy of the letter can be downloaded here. Following a significant downturn in the first quarter, U.S. equities saw a double-digit rise in the second quarter. The small-cap portfolio appreciated 2.7% (2.4% net) in the second quarter, lagging behind the Russell 2000 Index's 8.5% gain. Sector allocation contributed to the relative performance, while stock selection was a headwind. Please review the fund's top 5 holdings to gain insight into their key selections for 2025. In its second quarter 2025 investor letter, The London Company Small Cap Strategy highlighted stocks such as ACI Worldwide, Inc. (NASDAQ:ACIW). ACI Worldwide, Inc. (NASDAQ:ACIW) is a software company that develops, installs, and supports a wide range of software products and solutions to facilitate digital payments. The one-month return of ACI Worldwide, Inc. (NASDAQ:ACIW) was -3.09%, and its shares gained 4.07% of their value over the last 52 weeks. On July 28, 2025, ACI Worldwide, Inc. (NASDAQ:ACIW) stock closed at $44.52 per share, with a market capitalization of $4.67 billion. The London Company Small Cap Strategy stated the following regarding ACI Worldwide, Inc. (NASDAQ:ACIW) in its second quarter 2025 investor letter: "ACI Worldwide, Inc. (NASDAQ:ACIW) – ACIW was a bottom performer due to investor disappointment over unchanged guidance, despite robust results. The company's stable business, underpinned by a high proportion of recurring revenues and nearly a year of revenue visibility from its contracted backlog, supports our positive outlook. Sustained organic growth and insider buying by the CEO during the stock pullback reinforce confidence in ACIW's long-term potential." A businesswoman using a digital tablet, making a payment using the company's payment processing technology. ACI Worldwide, Inc. (NASDAQ:ACIW) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 29 hedge fund portfolios held ACI Worldwide, Inc. (NASDAQ:ACIW) at the end of the first quarter, which was 35 in the previous quarter. While we acknowledge the potential of ACI Worldwide, Inc. (NASDAQ:ACIW) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered ACI Worldwide, Inc. (NASDAQ:ACIW) and shared the list of Aristotle Capital Small Cap Equity Strategy's views on the company. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey.
